In vitro metabolism of chloroquine: identification of CYP2C8, CYP3A4, and CYP2D6 as the main isoforms catalyzing N-desethylchloroquine formation.

Drug Metabolism and Disposition : the Biological Fate of Chemicals
Denis ProjeanJulie Ducharme

Abstract

In humans, the antimalarial drug chloroquine (CQ) is metabolized into one major metabolite, N-desethylchloroquine (DCQ). Using human liver microsomes (HLM) and recombinant human cytochrome P450 (P450), we performed studies to identify the P450 isoform(s) involved in the N-desethylation of CQ. In HLM incubated with CQ, only DCQ could be detected. Apparent Km and Vmax values (mean +/- S.D.) for metabolite formation were 444 +/- 121 microM and 617 +/- 128 pmol/min/mg protein, respectively. In microsomes from a panel of 16 human livers phenotyped for 10 different P450 isoforms, DCQ formation was highly correlated with testosterone 6beta-hydroxylation (r = 0.80; p < 0.001), a CYP3A-mediated reaction, and CYP2C8-mediated paclitaxel alpha-hydroxylation (r = 0.82; p < 0.001). CQ N-desethylation was diminished when coincubated with quercetin (20-40% inhibition), ketoconazole, or troleandomycin (20-30% inhibition) and was strongly inhibited (80% inhibition) by a combination of ketoconazole and quercetin, which further corroborates the contribution of CYP2C8 and CYP3As. Of 10 cDNA-expressed human P450s examined, only CYP1A1, CYP2D6, CYP3A4, and CYP2C8 produced DCQ. CYP2C8 and CYP3A4 constituted low-affinity/high-capacity systems, whereas ...Continue Reading

References

Jan 1, 1992·Nephron·M R NampooryK V Johny
Oct 1, 1991·Archives of Biochemistry and Biophysics·D J WaxmanK Korzekwa
Apr 15, 1991·Biochemical Pharmacology·S LoftH E Poulsen
May 1, 1989·Journal of Clinical Pharmacology·E I EtteE A Brown-Awala
Feb 1, 1987·Seminars in Arthritis and Rheumatism·W Maksymowych, A S Russell
Sep 1, 1970·The Journal of Pharmacy and Pharmacology·A E RobinsonF E Camps
Nov 1, 1982·The Journal of Pharmacy and Pharmacology·S A Adelusi, L A Salako
Jul 18, 1983·The American Journal of Medicine·A H Mackenzie
Jan 1, 1983·European Journal of Clinical Pharmacology·M Frisk-HolmbergB Domeij-Nyberg
Jan 1, 1984·European Journal of Clinical Pharmacology·M Frisk-HolmbergB Domeij-Nyberg
Mar 1, 1983·British Journal of Clinical Pharmacology·O WalkerF Sjöqvist
Apr 1, 1983·British Journal of Clinical Pharmacology·L L GustafssonF Sjöqvist
Jul 1, 1996·Pharmaceutical Research·A Tsuji, I Tamai
Oct 1, 1996·Clinical Pharmacokinetics·J Ducharme, R Farinotti
Jan 16, 1999·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·S E Clarke
Oct 6, 1999·British Journal of Clinical Pharmacology·S J BaldwinR J Chenery
Jul 15, 2000·British Journal of Clinical Pharmacology·O O SimooyaG T Tucker
Sep 8, 2000·Clinical Pharmacokinetics·W Mück
Jan 3, 2001·British Journal of Clinical Pharmacology·C E OngJ O Miners
Jan 24, 2002·The Journal of Pharmacology and Experimental Therapeutics·Xue-Qing LiCollen M Masimirembwa

❮ Previous
Next ❯

Citations

Jul 12, 2008·Archives of Toxicology·Olavi PelkonenHannu Raunio
Dec 25, 2004·European Journal of Clinical Pharmacology·Jens RengelshausenIngeborg Walter-Sack
Jun 17, 2010·European Journal of Clinical Pharmacology·Kazeem A OshikoyaImti Choonara
Dec 23, 2009·Molecular Pharmaceutics·Xinyuan ZhangGus R Rosania
Nov 14, 2013·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Susan S Schiffman, Kristina I Rother
Oct 15, 2011·The Journal of Infectious Diseases·Giacomo M PaganottiDavid Modiano
Jan 21, 2010·Antimicrobial Agents and Chemotherapy·Harin A KarunajeewaTimothy M E Davis
Apr 26, 2012·Malaria Journal·Giacomo M PaganottiRita Romano
Mar 18, 2009·Pharmacogenomics·Rajeev K MehlotraPeter A Zimmerman
Apr 26, 2012·Future Medicinal Chemistry·Clément Roux, Christophe Biot
Feb 9, 2007·Pharmacogenomics·J P Gil, E Gil Berglund
Sep 2, 2014·Biological & Pharmaceutical Bulletin·Yuji MukaiNobuo Inotsume
Nov 18, 2010·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Bruno MégarbaneFrédéric J Baud
Jun 20, 2008·Journal of Pharmaceutical Sciences·Charles B DavisStephen A Ward
Sep 5, 2015·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Roslyn ThelingwaniCollen Masimirembwa
Jan 2, 2016·Pharmacological Reviews·Janne T BackmanPertti J Neuvonen
Jun 30, 2009·Annales de dermatologie et de vénéréologie·A SaussineB Crickx
Aug 22, 2007·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Zong-Ling XiaTong-Wei Yao
Jul 17, 2007·International Journal of Antimicrobial Agents·Jean-Marc RolainDidier Raoult
Jan 14, 2004·British Journal of Pharmacology·Caroline FradettePatrick Du Souich
Feb 1, 2007·Journal of Applied Toxicology : JAT·Akram JamshidzadehHamed Kashafi
Sep 15, 2007·The British Journal of Dermatology·R HügelR Gläser
Nov 1, 2007·Dermatologic Therapy·Sunil Kalia, Jan P Dutz
May 4, 2004·Best Practice & Research. Clinical Rheumatology·E TanakaN Kamatani
Jul 13, 2005·International Journal of Antimicrobial Agents·R Wielgo-PolaninP Lainé-Cessac
May 18, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Matthew M IppolitoCharles Flexner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.